Literature DB >> 28224700

Delivery of radiation therapy in resource-limited settings: A pilot quality assessment study.

Alexandra Power-Hays1, Paola Friedrich2, Gretchen Fernandez3, Naly A Cruz4, Karen Marcus5, Carlos Rodriguez-Galindo2, Luisa Collado3.   

Abstract

Progress has been made in resource-limited countries in treating acute lymphoblastic leukemia, but advances in solid malignancies have been slower. Multidisciplinary care coordination is challenging, assessing adherence to guidelines through quality improvement initiatives is essential. We characterized deviations from guidelines in the delivery of radiation in a middle-income country program as a pilot for evaluating adequacy of local control and as surrogate for integration of multidisciplinary care. One-third of patients for whom it was indicated did not receive radiation. Of the patients who received radiation, 95% had a deviation. This study underscores the importance of quality assessment in resource-limited settings.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  childhood cancer; low/middle-income countries (LMIC); radiation therapy

Mesh:

Year:  2017        PMID: 28224700      PMCID: PMC5608094          DOI: 10.1002/pbc.26480

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  14 in total

1.  Bridging the childhood cancer mortality gap between economically developed and low-income countries.

Authors:  Giuseppe Masera
Journal:  J Pediatr Hematol Oncol       Date:  2009-10       Impact factor: 1.289

2.  A prospective protocol for nasopharyngeal carcinoma in children and adolescents: the Italian Rare Tumors in Pediatric Age (TREP) project.

Authors:  Michela Casanova; Gianni Bisogno; Lorenza Gandola; Giovanni Cecchetto; Andrea Di Cataldo; Eleonora Basso; Paolo Indolfi; Paolo D'Angelo; Francesca Favini; Paola Collini; Paolo Potepan; Andrea Ferrari
Journal:  Cancer       Date:  2011-09-14       Impact factor: 6.860

3.  Prognostic factors and long-term outcomes of childhood nasopharyngeal carcinoma.

Authors:  Daniel Ka Leung Cheuk; Catherine A Billups; Michael G Martin; Cynthia R Roland; Raul C Ribeiro; Matthew J Krasin; Carlos Rodriguez-Galindo
Journal:  Cancer       Date:  2010-08-24       Impact factor: 6.860

4.  Pediatric sarcoma in Central America: outcomes, challenges, and plans for improvement.

Authors:  Paola Friedrich; Roberta Ortiz; Kelly Strait; Soad Fuentes; Yéssica Gamboa; Ingrid Arambú; María Ah-Chu-Sanchez; Wendy London; Carlos Rodríguez-Galindo; Federico Antillón-Klussmann; Fulgencio Báez
Journal:  Cancer       Date:  2012-09-12       Impact factor: 6.860

5.  Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.

Authors:  R Beverly Raney; David O Walterhouse; Jane L Meza; Richard J Andrassy; John C Breneman; William M Crist; Harold M Maurer; William H Meyer; David M Parham; James R Anderson
Journal:  J Clin Oncol       Date:  2011-02-28       Impact factor: 44.544

6.  Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803.

Authors:  Carola A S Arndt; Julie A Stoner; Douglas S Hawkins; David A Rodeberg; Andrea A Hayes-Jordan; Charles N Paidas; David M Parham; Lisa A Teot; Moody D Wharam; John C Breneman; Sarah S Donaldson; James R Anderson; William H Meyer
Journal:  J Clin Oncol       Date:  2009-09-21       Impact factor: 44.544

Review 7.  Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration.

Authors:  Jeffrey S Dome; Norbert Graf; James I Geller; Conrad V Fernandez; Elizabeth A Mullen; Filippo Spreafico; Marry Van den Heuvel-Eibrink; Kathy Pritchard-Jones
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

Review 8.  Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge.

Authors:  Carlos Rodriguez-Galindo; Paola Friedrich; Patricia Alcasabas; Federico Antillon; Shripad Banavali; Luis Castillo; Trijn Israels; Sima Jeha; Mhammed Harif; Michael J Sullivan; Thuan Chong Quah; Catherine Patte; Ching-Hon Pui; Ronald Barr; Thomas Gross
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

9.  Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.

Authors:  Brenda J Weigel; Elizabeth Lyden; James R Anderson; William H Meyer; David M Parham; David A Rodeberg; Jeff M Michalski; Douglas S Hawkins; Carola A S Arndt
Journal:  J Clin Oncol       Date:  2015-10-26       Impact factor: 44.544

10.  Barriers to effective treatment of pediatric solid tumors in middle-income countries: can we make sense of the spectrum of nonbiologic factors that influence outcomes?

Authors:  Paola Friedrich; Roberta Ortiz; Soad Fuentes; Yéssica Gamboa; María Sabina Ah Chu-Sanchez; Ingrid Carolina Arambú; Margarita Montero; Fulgencio Báez; Carlos Rodríguez-Galindo; Federico Antillón-Klussmann
Journal:  Cancer       Date:  2013-10-16       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.